News

UBS Maintains Neutral Rating on Formula One Holdings Amid Growth Change

UBS Maintains Neutral Rating on Formula One Holdings Amid Growth Change

UBS Initiates Coverage on Formula One Group

In recent market insights, UBS announced the initiation of its coverage on Formula One Group (FWONK) by assigning a Neutral rating. They foresee a shift in growth dynamics as the company enters a phase characterized by slower growth in the upcoming years.

Forecasting Growth Rates

Analysts at UBS have set a price target of $85 for the stock, indicating a shift toward more normalized growth after a period of rapid expansion that has marked previous years. They highlighted that while growth should continue, a decelerating trend is anticipated going forward. This projection stems from expected lower operating leverage regarding team payments, diminished upside potential from race promotions in the near future, and a more modest uplift from the upcoming U.S. rights renewal.

Projected Revenue and OIBDA Growth

The bank has projected that Formula One's revenue, along with its operating income before depreciation and amortization (OIBDA), will experience compound annual growth rates (CAGR) of 8% and 12% respectively from 2024 to 2026. This reflects a notable slowdown compared to the previous growth rates of 16% and 20% recorded between 2022 and 2024.

Valuation Insights

When examining the current valuation of Formula One, UBS observes that it stands at approximately 21 times OIBDA, which is consistent with the lower end of the company's historical range. This valuation is deemed justified, given the transition to more normalized growth metrics.

Potential Tailwinds from U.S. Media Rights Renewal

Furthermore, UBS considers the renewal of the U.S. linear media rights for the upcoming 2026 season as a potential avenue for positive growth, projecting a 1.6 times increase in the average annual value (AAV). Despite this optimistic outlook, they note that the impact may be somewhat limited, as U.S. rights contribute only about 3% to Formula One's primary revenue stream.

Viewership Trends and Projections

UBS pointed out that while viewership has seen low-single-digit increases during the current media rights deal, it pales in comparison to the staggering 70% rise witnessed during the prior agreement. This trend raises concerns about the potential for significant growth receding with the current deal.

Future Growth Opportunities

Looking toward the future, UBS is optimistic about additional growth opportunities that may arise from the Concorde Agreement as well as Formula 1’s recent strategic acquisition of MotoGP for $4.5 billion. These initiatives are expected to penetrate previously underdeveloped markets, albeit with warnings that such strategies will require time before they yield substantial results.

Challenges in the U.S. Market

UBS highlighted that the U.S. market holds considerable opportunities, yet currently, races are averaging only 30,000 to 40,000 viewers, a stark contrast to F1's overall U.S. viewership that remains below 5%. This discrepancy signifies an area with potential for growth that has yet to be fully unlocked.

Balancing Risks and Rewards

Even with a robust cash generation profile displayed by Formula 1, UBS believes that the present landscape harbors a balanced portfolio of risks and rewards. Navigating these waters as the company evolves will require keen strategic planning and execution.

Frequently Asked Questions

What is UBS's rating for Formula One Group?

UBS has given Formula One Group a Neutral rating as they forecast slower growth in the coming years.

What price target did UBS set for Formula One Group stock?

UBS has set a price target of $85 for Formula One Group stock.

What growth rates does UBS forecast for Formula One's revenue?

UBS projects an 8% revenue growth and 12% OIBDA growth CAGR from 2024 to 2026.

How does the current valuation of Formula One compare historically?

The current valuation sits at roughly 21 times OIBDA, which UBS deems to be near the low end of the historical range.

What role does U.S. media rights renewal play in Formula One's growth?

While potentially beneficial, the renewal of U.S. media rights is expected to have a limited impact on overall revenue, accounting for only about 3% of Formula One's primary revenue.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

RavenPack's Data Innovation: Sharpening Financial Analysis

Updated Category News Views 6

Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...

Continue Reading
Sony's Game-Changing Sensor Reshapes Medical Endoscopy

Updated Category News Views 0

In a world where medical tech innovation can make the difference between life and death, Sony’s latest feat will turn some heads in the healthcare industry. This ain’t about another PlayStation release; we’re talking the IMX742 CMOS image sensor crafted for single-use endoscopes. As far as breakthroughs go, the microscopic square sensor packs a surprising punch by...

Continue Reading
Sony's IMX742: Revolutionizing Endoscopic Imaging

Updated Category News Views 2

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

Continue Reading
EverSmith Rolls Out Training Hub to Propel Franchise Growth

Updated Category News Views 4

Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...

Continue Reading
Trilogy Metals Advances Arctic Project's Potential

Updated Category News Views 5

Trilogy Metals Completes Ambler Metals Field Work Alright, folks, let's dive into a mining story that should catch the discerning eye. Trilogy Metals (NYSE: TMQ) proudly wrapped up its 2026 field season at the Upper Kobuk Mineral Projects (UKMP), located in northwestern Alaska. And if you're neck-deep in the mining sector, this isn't just a thing on the periphery; it's a...

Continue Reading
Chemours Investors Face Crucial Class Action Deadline

Updated Category News Views 7

High Stakes for Chemours Shareholders Well, this isn’t your run-of-the-mill shareholder grumble. We're staring down an 18.63% plunge in Chemours’ stock—plenty to raise the eyebrows of anyone keeping tabs on this chemical giant. For those who snatched up Chemours shares between February 20 and August 4, 2026, the revelations about potential misstatements concerning...

Continue Reading
St. Croix Financial Hub: Game Changer or Fluff?

Updated Category News Views 5

You know, sometimes it feels like the financial world gets more tangled than a fishing line on a windy beach. This latest spiel coming out of St. Croix with all its big names and lofty promises—Governor Bryan’s 3rd Wall Street Financial District Hub Initiative—seems like one of those, but maybe it’s got more meat than hype. Half the pitch sounds like your typical...

Continue Reading
PuroClean Shines in Franchise Rankings with Global Growth

Updated Category News Views 3

Diversifying with Property Restoration Stroll through any franchise expo and the buzzwords are all there: growth, opportunity, scalability. But in the crowded room of glittery pitches, the ones really shaking things up are those that go beyond the razzle-dazzle—brands like PuroClean that stick it to the competition with real, boots-on-the-ground expansion. The...

Continue Reading
Pearl Meyer Bolsters Leadership Team with Key Additions

Updated Category News Views 4

In the fast-paced world of executive advising, Pearl Meyer just cranked up the heat, announcing the addition of four seasoned managing directors to their Leadership Advisory practice. These new folks are here to shake things up, with a strong focus on executive assessment, leadership effectiveness, and organizational transformation. Strategic Moves in Leadership Adding...

Continue Reading
MIAX Launches New Fertilizer Futures Amid Market Fluctuations

Updated Category News Views 7

MIAX Sets Sights on Fertilizer Futures Out of the blue, we’ve got MIAX—one of the major players in financial markets—tossing their hat into the ring with fertilizer futures. They aren’t just playing around; they’ve launched four new physically-settled fertilizer futures contracts. You might wonder, why fertilizers? Hang tight, I'll tell you. MIAX is tapping into...

Continue Reading

Top 5 Most Recently Viewed Articles

Inception Growth Extends Special Meeting and Redemption Deadline

Updated Category News Views 165

Inception Growth Acquisition Limited Postpones Special Meeting New York, June 26, 2025 - Inception Growth Acquisition Limited (NASDAQ: IGTA), a company formed for investment purposes, has decided to postpone its special meeting of shareholders originally scheduled for July 1, 2025. The new date for this significant event is now set for July 14, 2025, at 10:00 a.m. Hong...

Continue Reading
Market Trends Amid Inflation Concerns: Insights on Key Stocks

Updated Category News Views 98

Recent Market Performance and Its Implications As U.S. equities reached new record highs this week, a sudden halt in momentum arose as concerns regarding inflation cast shadows over future growth. Investors are now grappling with complex inflation data, which could significantly impact the Federal Reserve's strategy regarding interest rates. Inflation Data and Economic...

Continue Reading
Insight into Man Group PLC's Position Regarding Dalata Hotel Group

Updated Category News Views 96

Understanding Man Group PLC's Role in Recent Disclosures Man Group PLC, a distinguished player in the financial services sector, has provided significant updates regarding its position in Dalata Hotel Group plc. This disclosure is particularly relevant for investors tracking the dynamics within the hospitality and investment landscapes. Key Disclosure Information In...

Continue Reading
NBC Sports Makes History with Primetime Kentucky Oaks 2026

Updated Category News Views 173

NBC Sports Makes History with Primetime Kentucky Oaks 2026 Churchill Downs Incorporated and NBC Sports have announced an exciting new chapter in the legacy of the Kentucky Oaks. For the very first time, the renowned race will be televised in primetime, allowing fans to immerse themselves in the thrilling atmosphere of this esteemed event on the evening of May 1, 2026, at...

Continue Reading
Acadia Healthcare Facing Class Action: Legal Insights for Investors

Updated Category News Views 52

Overview of Acadia Healthcare's Legal Challenges Recent developments have brought Acadia Healthcare Company, Inc. (NASDAQ: ACHC) into the limelight due to allegations surrounding misleading business practices. This situation has led to a closer look at the company's operations and its level of transparency. Investigation into Securities Claims The Rosen Law Firm, a...

Continue Reading